Description

Zitaneo GM-IR-50/500/1 is a triple-action oral antidiabetic medication designed for better glycemic control in patients with Type 2 Diabetes Mellitus. It combines the benefits of:

• Sitagliptin (50 mg): A DPP-4 inhibitor that enhances the body’s natural ability to lower blood sugar levels by increasing incretin hormone levels.
• Metformin Hydrochloride (500 mg): A biguanide that reduces liver glucose production and improves insulin sensitivity.
• Glimepiride (1 mg): A sulfonylurea that stimulates insulin secretion from pancreatic beta cells, helping lower blood sugar effectively.

This combination therapy is effective in managing blood sugar levels, reducing the risk of complications associated with diabetes, and improving overall metabolic health. Regular exercise and a balanced diet are recommended for optimal results.

Indications:

• Type 2 Diabetes Mellitus (when monotherapy is insufficient)
• Patients requiring dual or triple therapy for better glycemic control

Key Benefits:
✔ Helps maintain steady blood glucose levels
✔ Reduces insulin resistance and glucose absorption
✔ Provides long-term diabetes management with fewer side effects